Phase
Condition
N/ATreatment
PKU sphere
Clinical Study ID
Ages > 16 Female
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Diagnosis of phenylketonuria (PKU) or hyperphenylalaninemia (hyperphe) whichrequires dietary management during pre-conception and/or pregnancy.
Aged 16 years and above.
Following dietary management advice pre-conceptually and/or during pregnancy, aimingfor phenylalanine levels of 120-250µmol/L.
Prior positive PKU sphere taste test completed as part of routine care.
Chosen to take part or full requirement of protein substitute as PKU spherepre-conceptually and/or during pregnancy.
Willingly given, written, informed consent from patient.
Participant is, in the opinion of the investigator, able to participate and cancomply with the study protocol.
Exclusion
Exclusion Criteria:
Conception of pregnancy without commencement of phe-restricted diet and bloodphenylalanine not maintained within target range by 10 weeks' gestation.
Patients with known soya, milk or fish allergies / intolerance.
Intake of pegvaliase or large neutral amino acids within 30 days prior to screeningvisit.
Patients who are currently participating in, plan to participate in, or haveparticipated in an interventional investigational drug, food or medical device trialwithin 30 days prior to screening visit.
Study Design
Study Description
Connect with a study center
Royal Victoria Hospital
Belfast,
United KingdomSite Not Available
University Hospital of Wales
Cardiff,
United KingdomSite Not Available
NHS Greater Glasgow and Clyde
Glasgow,
United KingdomSite Not Available
University College London Hospitals NHS Foundation Trust
London,
United KingdomSite Not Available
Salford Royal Hospital
Salford,
United KingdomSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.